34. 수중유형의 마이크로에멀젼을 이용한 케토프로펜의 외용제제화

지상철(Sang Cheol Chi),박은석(Eun Sok Park),최정교(Jung Gyo Choi) 한국약제학회 1997 한국약제학회 총회 및 학술대회 요지집 Vol.- No.27

N/A

케토프로펜 로오숀으로부터 약물의 피부투과

지상철(Sang Cheol Chi),박은석(Eun Seok Park),단현광(Hyun Kwang Tan),이윤석(Yun Seok Rhee) 한국응용약물학회 1997 Biomolecules & Therapeutics(구 응용약물학회지) Vol.5 No.4

The effects of formulation variables of topical lotion on the skin permeation of ketoprofen were evaluated using excised rat skins. The formulation variables were the amounts of poloxamer 407, drug and ethanol, and penetration enhancers. The Keshary-Chien diffusion cells were used for the diffusion study. The flux of ketoprofen linearly decreased as the concentration of poloxamer increased from 5% to 15% in the preparation, and linearly increased as the amount of drug increased. Penetration enhancers such as fatty acids and fatty alcohols showed markedly enhancing effects at the level of 5%. Among them, the highest flux was shown in linolenic acid. From these results, optimum formula containing 3% ketoprofen, 5% poloxamer 407, 40% ethanol and 5% linolenic acid having the flux of 537.6 ㎍/㎠/hr were noted.

Validation Process of HPLC Assay Methods of Drugs in Biological Samples

지상철,전흥원,Chi, Sang-Cheol,Jun, H.-Won 한국약제학회 1991 Journal of Pharmaceutical Investigation Vol.21 No.3

An HPLC assay method of a drug to be applied to the pharmacokinetic studies of the drug should be completely validated. The validation process for an HPLC assay method in a biological sample was discussed using the data obtained from the development of HPLC method for the simultaneous quantitation of verapamil and norverapamil in human serum. The validation criteria included were specificity, linearity, accuracy, precision, sensitivity, recovery, drug stability, and ruggedness of an assay method.

회원 학술보고 : 포스터 발표 / 1. Indomethacin 의 적출렛트피부 투과

감성훈(Sung Hoon Kam),이승우(Seung Woo Lee),지상철(Sang Cheol Chi) 한국약제학회 1993 한국약제학회 총회 및 학술대회 요지집 Vol.- No.23

흰쥐에서 DWP-04가 D-galactosamine에 의해 유도된 간독성의 보호효과

이정희,지상철,김석환,신영호,최종원,Lee Jung-Hee,Chi Sang Cheol,Kim Seok-Hwan,Shin Young-Ho,Choi Jongwon 한국생명과학회 2005 생명과학회지 Vol.15 No.3

This study was conducted to investigate the biological activity and hepatoprotective effect of DWP-04 [DDB : selenium yeast: glutathione (31.1 : 6.8 : 62.1(w/w/w)] in D-galactosamine (GaIN) intoxicated rats. The DWP-04 (50, 100 or 200 mg/kg) or its vehicle was orally administered everyday before the start of GaIN injection (400 mg/kg, ip) for two weeks and animal decapitated for 24 hrs after GaIN­injected. The activities of serum enzymes, markers of liver function, were increased in the GaIN group compared to normal group and significantly lowered in the DWP-04 pretreated group than in the GaIN group. Hepatic lipid peroxide level and activities of phase 1 enzymes were significantly higher than those of GaIN group compared to normal group and lower in the DWP-04 pretreated group than in the GaIN group, and phase II enzyme activities in liver were lower in the GaIN group than in the normal group and were increased in the DWP-04 pretreated group than in the GaIN group. Total hepatic glutathione content and glutathione biosynthesis enzymes were lower in the GaIN group than in the normal group and were increased in the DWP-04 pretreated group than in the GaIN group. Therefore, the current results indicated that DWP-04 administration alleviated the GaIN-induced adverse effect through enhancing the antioxidant enzyme activities. 간기능 보호 작용이 있는 것으로 알려진 DDB, selenium과 glutathione의 혼합제제인 DWP-04의 간보호 작용을 검토할 목적으로 DWP-04를 실험동물에 경구로 투여하고서 D-galactosamine으로 간독성을 유발하여 혈액의 변동 및 간 조직에서의 활성산소 생성계 및 해독계의 활성에 미치는 영향을 관찰한 결과 GaIN의 단독투여는 대조군에 비하여 혈중 간 기능 지표효소 및 간 조직에서의 지질과산화의 함량이 현저히 증가하였으나, DWP-04의 전처리로 현저히 감소되었다. CaIN의 단독 투여로 활성산소의 생성계인 phase 1계의 효소가 현저히 증가하던 것이 DWP-04의 처리로 억제되었으며 해독계인 phase II계의 효소는 GaIN의 투여로 대조군에 비하여 억제되던 것이 DWP-04의 전처리로 정상군에는 미치지 않으나 유의성 있게 증가되었다. 간 조직중 glutathine의 함량은 CaIN의 투여로 현저히 억제되었으며 DWP-04의 투여로 증가하였는데 이러한 결과는 DWP-04의 투여로 glutathione peroxidase의 활성보다는 $\gamma-glutamylcysteine$ synthetase의 활성을 조절한 결과로 생각된다. 이상의 결과를 종합하여 볼 때 DWP-04의 투여는 활성산소의 생성 및 해독계를 조절하므로서 GaIN으로 인한 간손상을 보호하는 효과가 있는 것으로 사료된다.

닛셀정에 대한 헤파필연질캡슐의 생물학적 동등성 평가

고인자,지상철,Ko, In-Ja,Chi, Sang-Cheol 대한약학회 2004 약학회지 Vol.48 No.6

Biphenyl dimethyl dicarboxylate (DDB) has been used for the treatment of chronic viral hepatitis B and drug-induced hepatitis through the inhibition of lipid peroxidation and c ovalent binding of drug metabolites to lipids of microsomes. The bioequivalence of two DDB products was evaluated according to the guidelines of KFDA. The test product was Hepaphil soft capsule(R) made by KMS Pharm. Co. Containing 3 mg DDB and the reference product was Nissel tablet(R) made by Taerim Pharm. Co. Containing 25 mg DDB. Twenty healthy male subjects, 25.4(22~30) years old and 66.7(54~77)kg, were divided into two groups and a randomized $2{\times}2$ cross-over study was employed. After two tablets or two capsules were orally administered, blood was taken at predetermined time intervals and the concentration of DDB in plasma was determined using a validated HPLC method with UV detector. Two pharmacokinetic parameters, $AUC_t$ and $C_{max}$, were calculated and analyzed statistically for the evaluation of bioequivalence of the two products. Analysis of variance was carried out using logarithmically transformed parameter values. The 90% confidence intervals of $AUC_t$ and $C_{max}$ were log 0.91~log1.00 and log 1.05~log 1.15, respectively. These values were within the acceptable bioequivalence intervals of log 0.8 to log 1.25. Thus, the criteria of the KFDA guidelines for the bioequivalence was satisfied, indicating that Hepaphil soft capsule is bioequivalent to Nissel tablet.

Effect of Tween 20 on the Penetration of Ketoprofen through Excised Rat Skin

김정주,지상철,심창구,김종국,Kim, Jung-Ju,Chi, Sang-Cheol,Shim, Chang-Koo,Kim, Chong-Kook 한국약제학회 1992 Journal of Pharmaceutical Investigation Vol.22 No.2

The effect of Tween 20 on the penetration of ketoprofen in aqueous vehicles through excised rat skin has been evaluated. The addition of Tween 20, up to 2%, in water containing ketoprofen decreased the penetration of ketoprofen through the skin compared with the reference vehicle without this surfactant. However, the addition of Tween 20 in ketoprofen aqueous vehicle increased diffusion parameter significantly which was compensated with the lowered partition parameter.

회원 학술보고 : 포스터 발표 / 15. 서방출성 flurbiprofen 정제의 제조 및 평가

이상철(Sang Cheol Lee),지상철(Sang Cheol Chi) 한국약제학회 1992 한국약제학회 총회 및 학술대회 요지집 Vol.- No.22

Quantitation of Flurbiprofen in Isopropyl Myristate by High Performance Liquid Chromatography

김현,지상철,Kim, Hyun,Chi, Sang-Cheol 한국약제학회 1992 Journal of Pharmaceutical Investigation Vol.22 No.1

An HPLC procedure with UV detection has been developed for the quantitation of flurbiprofen released into isopropyl myristate used as the receptor phase in an in vitro membraneless drug diffusion cell. The drug and the internal standard (oxaprozin) were extracted from isopropyl myristate with a mixture of dimethylsulfoxide:methanol:water (2:1:1) and quantitated using a reverse phase $C_{18}$ column. The chromatograms were completely free from interfering peaks, and the relative retention times of flurbiprofen and the internal standard were 4.9 and 6.8 min, respectively. Calibration plots were linear over the concentration range of $1-200\;{\mu}g/ml$ of flurbiprofen with correlation coefficients, all higher than 0.99. The mean intra-day precision and accuracy among three replicate sets of the assay in a day were 4.26 and 4.52%, respectively, whereas the mean inter-day precision and accuracy were 3.35 and 3.64%, respectively. The mean recovery of the drug was 92.5% over the calibration range. The method was simple, reliable and accurate for the quantitation of flurbiprofen in unpurified isopropyl myristate.

Poly(DL-lactide-co-glycolide) 나노입자의 표면 수식

오유미,정택규,지상철,신병철,Oh, Yu-Mi,Jung, Taek-Kyu,Chi, Sang-Cheol,Shin, Byung-Cheol 대한화학회 2003 대한화학회지 Vol.47 No.6

생분해성 고분자인 poly(DL-lactide-co-glycolide)(PLGA)를 자발적 유화용매 확산(spontaneous emulsification solvent diffusion, SESD)법을 이용하여 표면이 양이온으로 수식된 나노입자로 제조하고 그 특성을 조사하였다. 고분자 용액은 에탄올과 아세톤의 이종 혼합 용매를 사용하였고, 유화제는 양이온성 유화제인 cetyltrimethylammonium chloride(CTAC), tetradecyltrimethylammonium bromide(TTAB)와 비이온성 유화제인 polyethylene glycol-block-polypropylene glycol 공중합체(Lutrol F68)를 사용하였다. 제조한 입자에 결합한 백신은 인플루엔자($H_3N_2,\;H_1N_1$, B strain)이었고 입자에 대한 백신의 코팅 양은 NHS-fluorescein을 사용하여 확인하였다. 양이온성과 비이온성 유화제가 표면에 수식된 입자의 크기는 160-180 nm와 80-90 nm이었고 제타포텐셜은 $50{\sim}60$ mV, -10 mV이었다. 백신 코팅 후 입자의 크기는 양이온성이 380-400 nm, 비이온성은 별다른 크기 변화가 없었다. 양이온이 수식된 입자에 코팅된 백신의 양은 22.73 ${\mu}g$/mg이었다. We studied on preparation of nanoparticles modified surface using biodegradable polymer, poly(DL-lactide-co-glycolide) (PLGA). Two kinds of PLGA nanoparticles were prepared by a spontaneous emulsification solvent diffusion (SESD) method using cetyltrimethylammonium chloride (CTAC) and tetradecyltrimethylammonium bromide (TTAB) as a cationic surfactant and polyethylene glycol-block-polypropylene glycol copolymer (Lutrol F68) as a nonionic surfactant. Model protein was coated on the surface of nanoparticles by the ionic complexation. The model protein was that influenza vaccine ($H_3N_2,\;H_1N_1$, B strain) labeled with NHS-fluorescein. The sizes of cationic nanoparticles were 140-160 nm and the surface charges were 50-60 mV. The sizes of nonionic nanoprticles were 80-90 nm and the surface charge was -10 mV. After coating vaccine on the surface of nanoparticles, the sizes of cationic nanoparticles were increased to 380-400 nm and the size of nonionic nanoparticles was not increased. The amount of coated vaccine on the cationic nanoparticles was 22.73 ${\mu}g$/mg.